Oxidized LDL With Oxygen Therapy in Acute Coronary Syndrome.

计划入组 150 人 · 首次发布于 2019 年 2 月 5 日

To Assess the Efficacy and Safety of the Cardio Formulation in Reducing Oxidized LDL

计划入组 9 人 · 首次发布于 2020 年 3 月 23 日

Hämeenlinna Metabolic Syndrome Research Program: Oxidized LDL and Arterial Elasticity in Metabolic Syndrome and Controls (HMS-01)

计划入组 80 人 · 首次发布于 2010 年 5 月 3 日

Cellulose Oxidized

Oxidized Cellulose

Oxidized coenzyme A

C₂₁H₃₆N₇O₁₇P₃S

CHRYSEA LABS, LDA

Portugal

RSOCIALFORM - GERIATRIA, LDA

Portugal

PDL BIOPHARMA, INC.

United States

Abcentra Initiates Phase 2b FORTIFY Trial for Novel Anti-Inflammatory Cardiovascular Therapy Orticumab

CAR T Cell Therapy Shows 70% Reduction in Atherosclerotic Plaque in Preclinical Study

Precision Immunomodulation Emerges as Key Strategy to Balance Inflammation and Restore Tissue Homeostasis